A study from Saudi Arabia found that no major side effects were associated with AstraZeneca's COVID-19 vaccine AZD1222 and no breakthrough infections were seen, Arab News reported.
In line with the Saudi Vision 2030, the Ministry of Health (MOH) is undergoing a major transformation process to improve access, efficiency, and quality of care and to that end ...